She said what makes it different from other types of breast cancer is that women with the disease lack three hormone receptors known to fuel most breast cancer tumors: estrogen, progesterone and HER2. Tamoxifen and Herceptin, two of the most effective medications for treating breast cancer, don't work for triple negative breast cancer patients. "We know that women with a family history of breast cancer who have a BRCA1 mutation are most at risk," she said. Olopade said women born with the defective gene have a higher chance of getting breast cancer and at a younger age. Health Minute: More on triple negative breast cancer Â»